Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
The Guardian view on live music : a scheme to spread the sound around deserves support | Editorial
23/10/2025
Trump pardons founder of Binance, world’s largest crypto exchange
23/10/2025
Putin says he will never bow to US but concedes sanctions may cause ‘some losses’
23/10/2025
Asking immigrants for ‘A-level English’ is absurd | Letters
23/10/2025
London’s dominance of the Mercury prize | Letter
23/10/2025
Challenges of council restructure in Kent | Letter
23/10/2025